Results of Conservative Management of Clinically Localized Prostate Cancer

New England Journal of Medicine

Volumn 330, Issue 4, 1994, Pages 242-248

  Chodak, Gerald W ^a   Thisted, Ronald A ^a   Gerber, Glenn S ^a   Johansson, Jan Erik ^b   Adolfsson, Jan ^c   Jones, George W ^d   Chisholm, Geoff D ^e   Moskovitz, Boaz ^f   Livne, Pinhas M ^f   Warner, John ^g  

^a UNIVERSITY OF CHICAGO   (United States)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d HOWARD UNIVERSITY HOSPITAL   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONSERVATIVE TREATMENT; GEOGRAPHIC DISTRIBUTION; HORMONAL THERAPY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; BIAS (EPIDEMIOLOGY); HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0028158141     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199401273300403     Document Type: Article

References (41)

1. 1987 Annual cancer statistics review. Bethesda, Md.: National Cancer Institute, 1988. (NIH publication no. 88-2789).
2. Boring CC, Squires TS, Tong T Cancer statistics. CA Cancer J Clin 1992; 42: 19-38
3. Murphy GP, Natarajan N, Pontes JE, The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol 1982; 127: 928-934
4. Catalona WJ, Smith DS, Ratliff TL, Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156-1161
5. Gerber GS, Chodak GW Routine screening for cancer of the prostate. J Natl Cancer Inst 1991; 83: 329-335
6. Madsen PO, Graversen PH, Gasser TC, Corle DK Treatment of localized prostatic cancer: radical prostatectomy versus placebo: a 15-year follow-up. Scand J Urol Nephrol Suppl 1988; 110: 95-100
7. Wasson J, Cushman C, Bruskewitz RC, A structured literature review of treatment for localized prostate cancer. Arch Fam Med 1993; 2: 487-493
8. Franks LM Etiology, epidemiology and pathology of prostatic cancer. Cancer 1973; 32: 1092-1095
9. Holund B Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol 1980; 14: 29-35
10. Carter HB, Coffey DS. Prostate cancer: the magnitude of the problem in the United States. In: Coffey DS, Resnick MI, Dorr FA, Karr JP, eds. A multidisciplinary analysis of controversies in the management of prostate cancer. New York: Plenum Press, 1988:1-7.
11. Moskovitz B, Nitecki A, Richter Levin D Cancer of the prostate: is there a need for aggressive treatment? Urol Int 1987; 42: 49-52
12. Goodman CM, Busuttil A, Chisholm GD Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate. Br J Urol 1988; 62: 576-580
13. Jones GW Prospective, conservative management of localized prostate cancer. Cancer 1992; 70: Suppl: 307-310
14. Whitmore WF Jr, Warner JA, Thompson IM Jr Expectant management of localized prostatic cancer. Cancer 1991; 67: 1091-1096
15. Adolfsson J, Carstensen J, Lowhagen T Deferred treatment in clinically localized prostatic carcinoma. Br J Urol 1992; 69: 183-187
16. Johansson JE, Adami HO, Andersson SO, Bergstrom R, Krusemo UB, Kraaz W. Natural history of localized prostatic cancer: a population-based study in 223 untreated patients. Lancet 1989;1:799-803
17. Johansson JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L, Krusemo UB High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 1992; 267: 2191-2196
18. George NJR Natural history of localised prostatic cancer managed by conservative therapy alone. Lancet 1988; 1: 494-497
19. Newling DWW, Hall RR, Richards B, Robinson MRG, Hetherington JW. The natural history of prostatic cancer -- the argument for a no treatment policy. In: Pavone-Macaluso M, Smith PH, Bagshaw MA, eds. Testicular cancer and other tumors of the genitourinary tract. Vol. 18 of Life Sciences. New York: Plenum Press, 1985:443-8.
20. Orestano F. Problems of the wait-and-see policy in incidental carcinoma of the prostate. In: Altwein JE, Faul P, Schneider W, eds. Incidental carcinoma of the prostate. Berlin, Germany: Springer-Verlag, 1991:163-6.
21. Handley R, Carr TW, Travis D, Powell PH, Hall RR Deferred treatment for prostate cancer. Br J Urol 1988; 62: 249-253
22. Stewart LA, Parmar MKB Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993; 341: 418-422
23. Esposti PL Cytologic malignancy grading of prostate carcinoma by transrectal aspiration biopsy: a five-year follow-up study of 469 hormone-treated patients. Scand J Urol Nephrol 1971; 5: 199-209
24. Gaeta JF, Asirwatham JE, Miller G, Murphy GP Histologic grading of primary prostatic cancer: a new approach to an old problem. J Urol 1980; 123: 689-693
25. Gleason DF, Veterans Administration Cooperative Urological Research Group. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, ed. Urologic pathology: the prostate. Philadelphia: Lea & Febiger, 1977:171-98.
26. TNM classification of malignant tumors. 2nd ed. Geneva: International Union Against Cancer, 1974.
27. Harmer MH, ed. TNM classification of malignant tumors. 3rd ed. Geneva: International Union Against Cancer, 1978.
28. Prout GR Jr Diagnosis and staging of prostatic carcinoma. Cancer 1973; 32: 1096-1103
29. National Center for Health Statistics. Vital statistics of the United States, 1988. Vol. 2. Mortality. Part A. Section 6, Life tables. Washington, D.C.: Government Printing Office, 1988.
30. Livslangdstabeller For Artiondet 1971-1980. In: Official Statistics of Sweden: life tables, Vol. 3. Stockholm: Statistics Sweden, 1984:112-3.
31. Cox DR Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187-220
32. STATA reference manual. Release 3. 5th ed. Santa Monica, Calif.: Computing Resource Center, 1992.
33. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481
34. Mantel N, Haenszel W Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748
35. Hanks GE Radiotherapy or surgery for prostate cancer? Ten and fifteen-year results of external beam therapy. Acta Oncol 1991; 30: 231-237
36. Boxer RJ, Kaufman JJ, Goodwin WE Radical prostatectomy for carcinoma of the prostate: 1951-1976: a review of 329 patients. J Urol 1977; 117: 208-213
37. Elder JS, Jewett HJ, Walsh PC Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol 1982; 127: 704-706
38. Hanks GE External beam radiation treatment for prostate cancer: still the gold standard. Oncology (Huntingt) 1992; 6: 79-86, 89
39. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE A decision analysis of alternative treatment strategies for clinically localized prostate cancer: Prostate Patient Outcomes Research Team. JAMA 1993; 269: 2650-2658
40. Perez CA, Pilepich MV, Garcia D, Simpson JR, Zivnuska F, Hederman MA. Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology. In: Wittes RE, ed. Consensus Development Conference on the management of clinically localized prostate cancer. NCI monographs. No. 7. Bethesda, Md.: National Institutes of Health, 1988:85-94. (NIH publication no. 88-3005).
41. Gibbons RP. Total prostatectomy for clinically localized prostate cancer: long-term surgical results and current morbidity. In: Wittes RE, ed. Consensus Development Conference on the management of clinically localized prostate cancer. NCI monographs. No. 7. Bethesda, Md.: National Institutes of Health, 1988:123-6. (NIH publication no. 88-3005).